Avant Diagnostics, Inc Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
Avant Diagnostics, Inc reported Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) of -$86.40 thousand for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-03-13.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationPeriodIncreaseDecrease · last filed 2019-03-13
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-12-31 was -$86.40K.
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-09-30 was $31.85K, a 89.67% decline year-over-year.
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-06-30 was $111.04K.
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for the quarter ending 2018-03-31 was $89.80K.
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for fiscal 2018 was $143.06K.
- Avant Diagnostics, Inc fair value, net derivative asset (liability) measured on recurring basis, unobservable inputs reconciliation, period increase (decrease) for fiscal 2017 was -$26.46K.
| Period end | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 3 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 6 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 9 month | Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2018-12-31 | -$86.40K 10-Q · filed 2019-03-13 | -$54.55K derived: sum of 2 quarters · filed 2019-03-13 | $56.48K derived: sum of 3 quarters · filed 2019-03-13 | $146.28K derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-09-30 | $31.85K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $142.89K derived: sum of 2 quarters · filed 2019-03-01 | $232.68K derived: sum of 3 quarters · filed 2019-03-01 | $143.06K 10-K · filed 2019-03-01 |
| 2018-06-30 | $111.04K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-01-30 | $200.83K derived: sum of 2 quarters · filed 2019-01-30 | $111.21K 10-Q · filed 2019-01-30 | $419.46K derived: sum of 4 quarters · filed 2019-01-30 |
| 2018-03-31 | $89.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-09 | $175.00 10-Q · filed 2019-01-09 | $308.42K derived: sum of 3 quarters · filed 2019-01-09 | |
| 2017-12-31 | -$89.62K 10-Q · filed 2018-12-28 | $218.63K derived: sum of 2 quarters · filed 2018-12-28 | ||
| 2017-09-30 | $308.25K derived: 10-K 12 month − 10-Q 9 month · filed 2018-12-04 | -$26.46K 10-K · filed 2018-12-04 | ||
| 2017-06-30 | -$334.71K 10-Q · filed 2018-12-04 |